Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Atea Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Hospitalized or in a hospital-affiliated confinement facility
SARS-CoV-2 positive
Initial COVID-19 symptom onset within 5 days prior to Screening
SpO2 ≥ 93% on room air or requires ≤ 2L/min oxygen by nasal cannula or mask to maintain SpO2 ≥ 93%
Must also have a history of at least one of the following known risk factors for poor outcomes: obesity (BMI\>30), hypertension, diabetes or asthma.
You may not be if
Severe or critical COVID-19 illness: RR ≥30, HR ≥125, SpO2 \<93% on room air or requires \>2L/min oxygen by nasal cannula or mask to maintain SpO2 ≥93%, systolic blood pressure \< 90 mm Hg, diastolic blood pressure \< 60 mm Hg or PaO2/FiO2 \<300
Requires mechanical ventilation
Lobar or segmental consolidation on chest imaging.
Treatment with other drugs thought to possibly have activity against SARS-CoV-2
ALT or AST \> 5 x upper limit of normal (ULN)
Female subject is pregnant or breastfeeding
Has received or is expected to receive any dose of a SARS-CoV-2 vaccine before the Day 14 visit (Part B).
